Congress designates rare cancer awareness day, calls for research funding
H.Res. 732 — Expressing support for the designation of September 30, 2025, as "Rare Cancer Day" to highlight the challenges patients with rare cancers face and to raise awareness and support efforts to improve early diagnosis and treatment. · Filed by Mike Kelly (R-PA) · 4 cosponsors · Introduced Sep 17, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This is a symbolic House resolution designating September 30, 2025, as 'Rare Cancer Day' to raise public awareness about rare cancers, which affect about 1 in 5 cancer patients and have lower survival rates than common cancers. The resolution calls for increased awareness of rare cancer symptoms, better early detection, partnerships between medical and scientific fields, and dedicated funding for research and treatment development—but it creates no new law, appropriation, or mandate.
Why we flagged it
This is a non-binding symbolic resolution expressing congressional support for a designated awareness day and encouraging (but not mandating) research funding and clinical partnerships for rare cancer diagnosis and treatment.
Who stands to gain
pharmaceutical companies (potential future research funding); medical device manufacturers (potential diagnostic innovation); research institutions and academic medical centers